Recurrent Cervical Carcinoma

Preferred Label : Recurrent Cervical Carcinoma;

NCIt synonyms : Relapsed Carcinoma of Cervix Uteri; Relapsed Cervix Uteri Carcinoma; Relapsed Carcinoma of the Cervix; Recurrent Cervix Uteri Carcinoma; Relapsed Cervical Carcinoma; Recurrent Carcinoma of Uterine Cervix; Relapsed Carcinoma of Uterine Cervix; Relapsed Uterine Cervix Carcinoma; Recurrent Carcinoma of the Cervix; Recurrent Carcinoma of Cervix; Relapsed Cervix Carcinoma; Relapsed Carcinoma of the Uterine Cervix; Relapsed Carcinoma of the Cervix Uteri; Recurrent Carcinoma of Cervix Uteri; Relapsed Carcinoma of Cervix; Cervical Carcinoma Recurrent; Recurrent Carcinoma of the Cervix Uteri; Recurrent Uterine Cervix Carcinoma; Recurrent Carcinoma of the Uterine Cervix;

NCIt related terms : Recurrent Cervical Cancer;

NCIt definition : The reemergence of cervical carcinoma after a period of remission.;

Neoplastic status : Malignant;

Details

Origin ID

C7804;

UMLS CUI

C0278579;

Currated CISMeF NLP mapping
- Carcinoma cervix recurrent [MedDRA LLT]
- Carcinoma uterine cervix recurrent [MedDRA LLT]
- Cervical cancer recurrent [MedDRA LLT]
- Cervical carcinoma recurrent [MedDRA LLT]
- Cervix carcinoma recurrent [MedDRA Preferred Term]
- recurrent uterine cervix cancer [Disease (Nov.)]
Disease excludes abnormal cell
- Malignant Stromal Cell [NCIt concept]
- Neoplastic Smooth Muscle Cell [NCIt concept]
Has associated anatomic sites
- Cervix Uteri [NCIt concept]
- Female Reproductive System [NCIt concept]
- Genitourinary System [NCIt concept]
- Reproductive System [NCIt concept]
- Uterus [NCIt concept]
Protocole(s) indiqué(s)
- Bevacizumab/Cisplatin/Paclitaxel Regimen [NCIt concept]
- Bevacizumab/Paclitaxel/Topotecan Regimen [NCIt concept]
- Cisplatin/Topotecan Regimen [NCIt concept]
Semantic type(s)
- Neoplastic Process [UMLS semantic type]
UMLS correspondences (same concept)
- Carcinoma cervix recurrent [MedDRA LLT]
- Carcinoma uterine cervix recurrent [MedDRA LLT]
- Cervical cancer recurrent [MedDRA LLT]
- Cervical carcinoma recurrent [MedDRA LLT]
- Cervix carcinoma recurrent [MedDRA Preferred Term]
- Cervix uteri cancer recurrent [MedDRA LLT]
- recurrent uterine cervix cancer [Disease (Nov.)]
concept_is_in_subset
- CTRP Disease Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
disease_excludes_finding
- Benign Cellular Infiltrate [NCIt concept]
disease_has_abnormal_cell
- Malignant Cell [NCIt concept]
- Malignant Epithelial Cell [NCIt concept]
- Neoplastic Cell [NCIt concept]
- Neoplastic Epithelial Cell [NCIt concept]
disease_has_finding
- Carcinomatous Component Present [NCIt concept]
- Epithelial Component Present [NCIt concept]
- Malignant Cellular Infiltrate [NCIt concept]
- Recurrent Disease [NCIt concept]
disease_has_normal_cell_origin
- Epithelial Cell [NCIt concept]
disease_has_normal_tissue_origin
- Cervix Epithelium [NCIt concept]
- Epithelial Tissue [NCIt concept]
disease_has_primary_anatomic_site
- Cervix Uteri [NCIt concept]
- Female Reproductive System [NCIt concept]
- Genitourinary System [NCIt concept]
- Uterus [NCIt concept]
disease_mapped_to_gene
- FHIT Gene [NCIt concept]
- MYC Gene [NCIt concept]
- TP53 Gene [NCIt concept]
disease_may_have_molecular_abnormality
- ERBB2 Gene Amplification [NCIt concept]
- FHIT Gene Inactivation [NCIt concept]
- MYC Gene Amplification [NCIt concept]
- TP53 Gene Inactivation [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients